Interpace Biosciences Market Cap

Interpace Biosciences has a market cap or net worth of $5.66 million as of April 10, 2025. Its market cap has increased by 21.31% in one year.

Market Cap

5.66M

Enterprise Value

10.06M

Revenue

46.93M

Ranking

n/a

PE Ratio

3.12

Stock Price

$1.28

Market Cap Chart

Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 5.66M, a decrease of -97.45%. That is a compound annual growth rate of -12.75%.

Market Cap History

Date	Market Cap	% Change
Apr 9, 2025	4.73M	-60.14%
Dec 31, 2024	11.87M	152.98%
Dec 29, 2023	4.69M	5.76%
Dec 30, 2022	4.44M	-85.77%
Dec 31, 2021	31.18M	145.72%
Dec 31, 2020	12.69M	-33.55%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SS Innovations International	1.71B
Endo Inc.	1.69B
Nika Pharmaceuticals	1.02B
Veradigm	678.31M
Elite Pharmaceuticals	412.10M
Glass House Brands	309.26M
CytoDyn	265.47M
Northwest Biotherapeutics	264.38M

Market Cap Rankings